APA (7th ed.) Citation

Gregory, M. D., Ofosu-Asante, K., Lazarte, J. M. S., Puente, P. E., Tawfeeq, N., Belony, N., . . . Lamango, N. S. Treatment of a mutant KRAS lung cancer cell line with polyisoprenylated cysteinyl amide inhibitors activates the MAPK pathway, inhibits cell migration and induces apoptosis. Public Library of Science (PLoS).

Chicago Style (17th ed.) Citation

Gregory, Matthew D., Kweku Ofosu-Asante, Jassy Mary S. Lazarte, Pablo E. Puente, Nada Tawfeeq, Nadine Belony, Yong Huang, Ite A. Offringa, and Nazarius S. Lamango. Treatment of a Mutant KRAS Lung Cancer Cell Line with Polyisoprenylated Cysteinyl Amide Inhibitors Activates the MAPK Pathway, Inhibits Cell Migration and Induces Apoptosis. Public Library of Science (PLoS).

MLA (9th ed.) Citation

Gregory, Matthew D., et al. Treatment of a Mutant KRAS Lung Cancer Cell Line with Polyisoprenylated Cysteinyl Amide Inhibitors Activates the MAPK Pathway, Inhibits Cell Migration and Induces Apoptosis. Public Library of Science (PLoS).